Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome

21 Oct 2015

Abstract excerpt

// Ebba Sohlberg 1 , Aline Pfefferle 1 , Sandra Andersson 1 , Bettina C. Baumann 1 , Eva Hellström-Lindberg 2 and Karl-Johan Malmberg 1,3,4 1 Department of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden 2 Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune and Inflammatory Disorders Research
Share to Hematopoietic Stem Cell Transplantation
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26497557
DOI: 10.18632/oncotarget.6213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndromePMID 26497557Read ↗

Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.Semantic proximity Read ↗

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related diseaseSemantic proximity Read ↗

Immunological effects of hypomethylating agents.Semantic proximity Read ↗

Epigenetic control of S100A8/A9-driven monocytic inflammation licenses anti-leukemic functionality of immature NK cells during hematopoietic stem cell differentiationSemantic proximity Read ↗

Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes.Semantic proximity Read ↗

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesSemantic proximity Read ↗

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulationSemantic proximity Read ↗

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancersSemantic proximity Read ↗

Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.Semantic proximity Read ↗

5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.Semantic proximity Read ↗

Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.Semantic proximity Read ↗

Azacitidine differentially affects CD4pos T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.